Stada Arzneimittel

ots Ad hoc-Service: STADA Arzneimittel AG STADA invests in Biogenerics-Project

The sender is solely responsible for the contents of this announcement. -----------------------------------------------------

    Bad Vilbel (ots Ad hoc-Service) -            STADA Arzneimittel AG, based in Bad Vilbel near Frankfurt, today announced the founding of a German stock corporation to develop and market biotechnological generics. The new company has already concluded a letter of intent with an experienced partner from the industry, covering the development and later also the production of selected biotechnological generics. Apart from STADA, other investors are also interested to take a stake in the new company. Following the conclusion of the development and approval of the biogeneric drugs, these will be marketed by STADA in all countries where STADA has its own marketing organsiation, according to a license agreement between the new company and STADA. STADA's board expects to see the first results no earlier than 2003. Further informationen on STADA Arzneimittel AG are available on the Internet at

    End of message ----------------------------------------------------- Internet:

Original-Content von: Stada Arzneimittel, übermittelt durch news aktuell

Weitere Meldungen: Stada Arzneimittel

Das könnte Sie auch interessieren: